GoodRx offers founders $500M, nets $100M investment from Silver Lake, and makes quiet acquisition before IPO

GoodRx is a rare breed of modern tech IPO: a startup that is actually profitable and heading to the public markets. The consumer service offers coupons on prescriptions redeemable at pharmacies that can save customers significant money on their monthly drug prices.
The company filed an amended S-1 with the SEC this morning, and that included three pieces of news that hadn’t previously been reported.
First and most significantly, the company notes in its filing that it is offering its two co-founders, Douglas Hirsch and Trevor Bezdek, approximately 25 million in stock, at what the company placed as a fair-market value of $533.3 million. That stock has both a time-based component and a performance-based component, and is designed to incentivize the duo to commit to the company for the long-term.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Ноябрь 2020    »